J&J says in talks with Indian government for trial of single-dose vaccine
2 Min Read BENGALURU (Reuters) - Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. FILE PHOTO: Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton/File Photo The U.S. drugs and healthcare giant’s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa. The news come...